Atara Biotherapeutics (ATRA) EBIT (2013 - 2026)
Atara Biotherapeutics (ATRA) reported EBIT of -$3.4 million for Q1 2026, down 108.68% on a YoY basis from $38.8 million in Q1 2025, and up 89.32% quarter-over-quarter from -$31.6 million in Q4 2025.
Atara Biotherapeutics (ATRA) EBIT (2013 - 2026) Analysis & Trends
Atara Biotherapeutics has reported EBIT for 14 years, with the latest figure at -$3.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 108.68% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$35.3 million (down 163.65% YoY), and the FY2025 full-year result was $6.9 million, up 108.23% from the prior year.
- EBIT for Q1 2026 stood at -$3.4 million, up from -$31.6 million in the prior quarter.
- The five-year high for EBIT was $38.8 million in Q1 2025, with the low at -$88.2 million in Q1 2022.
- Historically, EBIT has averaged -$37.4 million across 5 years, with a median of -$31.6 million in 2025.
- The largest YoY upside for EBIT was 224.18% in 2025 against a maximum downside of 158.58% in 2025.
- Atara Biotherapeutics' EBIT stood at -$75.5 million in 2022, then climbed by 20.62% to -$60.0 million in 2023, then soared by 79.65% to -$12.2 million in 2024, then plunged by 158.58% to -$31.6 million in 2025, then soared by 89.32% to -$3.4 million in 2026.
- The last three EBIT figures came in at -$3.4 million (Q1 2026), -$31.6 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | -3.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.37 Mn |
| Dec 31, 2025 | -31.55 Mn |
| Sep 30, 2025 | -3.57 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 38.80 Mn |
| Dec 31, 2024 | -12.20 Mn |
| Sep 30, 2024 | -21.76 Mn |
| Jun 30, 2024 | -18.23 Mn |
| Mar 31, 2024 | -31.25 Mn |
| Dec 31, 2023 | -59.96 Mn |
| Sep 30, 2023 | -69.61 Mn |
| Jun 30, 2023 | -71.41 Mn |
| Mar 31, 2023 | -75.02 Mn |
| Dec 31, 2022 | -75.54 Mn |
| Sep 30, 2022 | -84.62 Mn |
| Jun 30, 2022 | -32.13 Mn |
| Mar 31, 2022 | -88.22 Mn |
| Dec 31, 2021 | -93.40 Mn |
| Sep 30, 2021 | -84.81 Mn |
| Jun 30, 2021 | -84.00 Mn |